Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 4:07 PM
Ignite Modification Date:
2025-12-24 @ 4:07 PM
NCT ID:
NCT02740166
Eligibility Criteria:
Inclusion Criteria:
* Age of 20 to 80 years
* Cirrhotic patients with acute or recent esophageal variceal bleeding proven by an endoscopy
* Stable hemodynamic condition for at least 3 days after banding ligation
Exclusion Criteria:
* Hepatocellular carcinoma or other malignancy
* Stroke or active sepsis
* Chronic kidney disease under renal replacement therapy
* Contraindications to non-selective beta-blockers
* A history of non-selective beta-blockers use, sclerotherapy, banding ligation, transjugular intrahepatic porto-systemic shunt, or shunt surgery
* Serum total bilirubin \>10 mg/dL
* Grade III/IV hepatic encephalopathy
* Refractory ascites
* Hepato-renal syndrome
* Pregnancy
* Severe heart failure (NYHA Fc III/IV)
* Bronchial asthma or chronic obstructive pulmonary disease
* Second or third degree atrioventricular block
* Sick sinus syndrome
* Pacemaker use
* Severe hypotension
* Refusal to participate
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
20 Years
Maximum Age:
80 Years
Study:
NCT02740166
Study Brief:
Protocol Section:
NCT02740166